Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dendritic Cells | 6 | 2023 | 2725 | 0.820 |
Why?
|
Histiocytes | 2 | 2022 | 103 | 0.800 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2017 | 30 | 0.690 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 4 | 2022 | 1378 | 0.650 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1060 | 0.630 |
Why?
|
Tumor Escape | 1 | 2021 | 349 | 0.630 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 671 | 0.570 |
Why?
|
Antigens | 1 | 2022 | 1466 | 0.560 |
Why?
|
Interferons | 3 | 2023 | 706 | 0.560 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2015 | 35 | 0.540 |
Why?
|
Lymphoma, T-Cell | 1 | 2017 | 299 | 0.510 |
Why?
|
Autoimmune Diseases | 2 | 2020 | 2136 | 0.510 |
Why?
|
Gene Silencing | 1 | 2021 | 1538 | 0.490 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1607 | 0.490 |
Why?
|
Immunologic Memory | 1 | 2020 | 1348 | 0.470 |
Why?
|
Inflammation | 8 | 2024 | 10634 | 0.450 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2942 | 0.440 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 704 | 0.420 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 534 | 0.400 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 354 | 0.380 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 605 | 0.380 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3523 | 0.370 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 390 | 0.350 |
Why?
|
Skin | 1 | 2023 | 4363 | 0.350 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5670 | 0.330 |
Why?
|
T-Lymphocytes | 5 | 2022 | 10182 | 0.330 |
Why?
|
Hematologic Neoplasms | 4 | 2023 | 1831 | 0.330 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2013 | 986 | 0.300 |
Why?
|
NF-kappa B | 1 | 2015 | 2501 | 0.290 |
Why?
|
Interleukin-17 | 1 | 2012 | 900 | 0.270 |
Why?
|
Cytokines | 1 | 2020 | 7326 | 0.270 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 421 | 0.260 |
Why?
|
Myocarditis | 1 | 2013 | 771 | 0.260 |
Why?
|
Antiviral Agents | 1 | 2018 | 2987 | 0.260 |
Why?
|
Melanoma, Experimental | 2 | 2019 | 561 | 0.260 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4837 | 0.260 |
Why?
|
Interferon-gamma | 1 | 2013 | 3203 | 0.250 |
Why?
|
Nitric Oxide | 1 | 2013 | 2131 | 0.240 |
Why?
|
Immune Tolerance | 1 | 2013 | 2258 | 0.240 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 91 | 0.230 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 51 | 0.230 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 111 | 0.230 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4419 | 0.200 |
Why?
|
Endothelial Cells | 3 | 2014 | 3478 | 0.190 |
Why?
|
Interleukin-1beta | 2 | 2024 | 972 | 0.190 |
Why?
|
Nissl Bodies | 1 | 2020 | 16 | 0.190 |
Why?
|
Cell Movement | 2 | 2014 | 5216 | 0.190 |
Why?
|
Dioxygenases | 1 | 2022 | 316 | 0.190 |
Why?
|
Macrophages | 3 | 2019 | 5657 | 0.180 |
Why?
|
Atherosclerosis | 2 | 2014 | 3444 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2016 | 1434 | 0.170 |
Why?
|
Clone Cells | 1 | 2023 | 1692 | 0.170 |
Why?
|
Menopause, Premature | 1 | 2020 | 132 | 0.170 |
Why?
|
Myeloid Cells | 1 | 2023 | 809 | 0.170 |
Why?
|
Penicillin G Benzathine | 1 | 2018 | 24 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 381 | 0.160 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 44 | 0.160 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 254 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2019 | 224 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2017 | 1620 | 0.160 |
Why?
|
Organ Specificity | 1 | 2023 | 2007 | 0.160 |
Why?
|
Mutation | 10 | 2023 | 29784 | 0.160 |
Why?
|
Single-Cell Analysis | 4 | 2022 | 2183 | 0.160 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2513 | 0.150 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 207 | 0.150 |
Why?
|
Cell Death | 1 | 2023 | 1708 | 0.150 |
Why?
|
Enteric Nervous System | 1 | 2020 | 189 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2021 | 1366 | 0.150 |
Why?
|
DNA Transposable Elements | 1 | 2021 | 748 | 0.150 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2019 | 134 | 0.150 |
Why?
|
Humans | 43 | 2024 | 744220 | 0.150 |
Why?
|
Antigens, Viral | 1 | 2021 | 1035 | 0.140 |
Why?
|
Loss of Heterozygosity | 2 | 2017 | 684 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2022 | 817 | 0.140 |
Why?
|
Adenosine Deaminase | 1 | 2018 | 241 | 0.140 |
Why?
|
Flow Cytometry | 3 | 2019 | 5974 | 0.140 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3584 | 0.140 |
Why?
|
Mice | 14 | 2023 | 81178 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2016 | 193 | 0.140 |
Why?
|
Bacillus cereus | 1 | 2015 | 35 | 0.130 |
Why?
|
Syphilis | 1 | 2018 | 227 | 0.130 |
Why?
|
Neoplasms | 2 | 2023 | 21672 | 0.130 |
Why?
|
Animals | 18 | 2023 | 168788 | 0.130 |
Why?
|
Gout | 1 | 2022 | 573 | 0.130 |
Why?
|
Signal Transduction | 5 | 2019 | 23404 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 805 | 0.130 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 3385 | 0.130 |
Why?
|
Meningoencephalitis | 1 | 2015 | 78 | 0.130 |
Why?
|
Chromosomes, Human | 1 | 2017 | 457 | 0.130 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2014 | 107 | 0.120 |
Why?
|
Cell Lineage | 1 | 2023 | 2504 | 0.120 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15161 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2021 | 1821 | 0.120 |
Why?
|
Autoantibodies | 1 | 2022 | 2038 | 0.120 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 104 | 0.110 |
Why?
|
ras Proteins | 1 | 2019 | 1060 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2014 | 275 | 0.110 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1039 | 0.110 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 341 | 0.110 |
Why?
|
Hematopoiesis | 4 | 2023 | 2069 | 0.110 |
Why?
|
Genes, Tumor Suppressor | 1 | 2017 | 1097 | 0.110 |
Why?
|
Cell-Derived Microparticles | 1 | 2014 | 168 | 0.110 |
Why?
|
Leukocyte Rolling | 1 | 2012 | 72 | 0.110 |
Why?
|
Endothelium, Vascular | 3 | 2014 | 4455 | 0.100 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9438 | 0.100 |
Why?
|
Virus Diseases | 1 | 2018 | 711 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1415 | 0.100 |
Why?
|
Genetic Engineering | 1 | 2017 | 952 | 0.100 |
Why?
|
Coronary Artery Disease | 2 | 2022 | 6489 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2461 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1525 | 0.100 |
Why?
|
Chromatin | 2 | 2021 | 2934 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.100 |
Why?
|
Lymphoma, B-Cell | 1 | 2017 | 931 | 0.100 |
Why?
|
Immunotherapy | 2 | 2023 | 4440 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 847 | 0.090 |
Why?
|
Virus Replication | 1 | 2018 | 2534 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2019 | 3201 | 0.090 |
Why?
|
Female | 21 | 2022 | 380197 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4477 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1903 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3598 | 0.090 |
Why?
|
RNA, Viral | 1 | 2018 | 2902 | 0.090 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 21824 | 0.080 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1866 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2011 | 675 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3921 | 0.080 |
Why?
|
Inflammasomes | 2 | 2023 | 494 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5169 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2018 | 2958 | 0.080 |
Why?
|
Chemokines | 1 | 2012 | 969 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3703 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1940 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 1596 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8426 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1416 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18027 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2020 | 13036 | 0.060 |
Why?
|
Genomics | 2 | 2019 | 5722 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3567 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4752 | 0.060 |
Why?
|
Male | 18 | 2021 | 350027 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2019 | 1880 | 0.060 |
Why?
|
Aged | 11 | 2021 | 163253 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7937 | 0.060 |
Why?
|
Adult | 12 | 2021 | 214035 | 0.050 |
Why?
|
Middle Aged | 12 | 2021 | 213367 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2013 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 2988 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2538 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 147 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2019 | 16687 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1789 | 0.050 |
Why?
|
Endoplasmic Reticulum, Rough | 1 | 2020 | 21 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9335 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17449 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2014 | 14556 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7179 | 0.040 |
Why?
|
Reed-Sternberg Cells | 1 | 2019 | 73 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5853 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 99 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1731 | 0.040 |
Why?
|
Lysosomes | 1 | 2023 | 893 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 713 | 0.040 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2019 | 132 | 0.040 |
Why?
|
Olfactory Bulb | 1 | 2019 | 200 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2019 | 168 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2020 | 171 | 0.040 |
Why?
|
Ileum | 1 | 2020 | 565 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 2019 | 315 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2019 | 553 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 895 | 0.040 |
Why?
|
RNA Editing | 1 | 2018 | 148 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2018 | 290 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 342 | 0.040 |
Why?
|
Ribosomes | 1 | 2020 | 500 | 0.040 |
Why?
|
Doxycycline | 1 | 2018 | 326 | 0.040 |
Why?
|
Uric Acid | 1 | 2022 | 765 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6352 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6893 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 8860 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2014 | 3144 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3256 | 0.030 |
Why?
|
Contact Tracing | 1 | 2018 | 273 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 688 | 0.030 |
Why?
|
Apoptosis | 2 | 2022 | 9728 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 531 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3294 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2014 | 29 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 2014 | 6 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 927 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1355 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1814 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12207 | 0.030 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 42 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
Neck | 1 | 2018 | 696 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2014 | 188 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13668 | 0.030 |
Why?
|
Risk Factors | 4 | 2023 | 72280 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12781 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1786 | 0.030 |
Why?
|
Azepines | 1 | 2014 | 336 | 0.030 |
Why?
|
Colon | 1 | 2020 | 1772 | 0.030 |
Why?
|
E-Selectin | 1 | 2014 | 579 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 707 | 0.030 |
Why?
|
Prospective Studies | 3 | 2021 | 53280 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Acetylation | 1 | 2014 | 1085 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2124 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 1221 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1940 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2034 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2014 | 794 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
RNA Polymerase II | 1 | 2014 | 551 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 418 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1623 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2924 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10480 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1849 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2751 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57768 | 0.020 |
Why?
|
Mitochondria | 1 | 2022 | 3520 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 911 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2749 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29050 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3557 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2540 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2944 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4289 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9735 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12801 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5881 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2011 | 713 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1751 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9647 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12355 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11493 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.020 |
Why?
|
Genotype | 1 | 2019 | 12956 | 0.020 |
Why?
|
Histones | 1 | 2014 | 2600 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2011 | 1613 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10250 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12961 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13280 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9392 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 56436 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8661 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20945 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12742 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2014 | 7723 | 0.010 |
Why?
|
Child | 2 | 2019 | 77679 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15525 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 85759 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39045 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19227 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2017 | 77426 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6274 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 13990 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40559 | 0.010 |
Why?
|
Infant | 1 | 2018 | 35129 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 7908 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 40992 | 0.010 |
Why?
|
United States | 1 | 2021 | 69867 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20817 | 0.010 |
Why?
|
HIV Infections | 1 | 2018 | 16718 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20123 | 0.010 |
Why?
|
Brain | 1 | 2018 | 26413 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63119 | 0.010 |
Why?
|